InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Baynes Roy D., 董事. Director active across 4 companies, notably Travere Therapeutics, Inc.. In total, 47 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.4m. Activity tracked since 14 May 2021. The latest transaction was filed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Baynes Roy D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报47 总计
1,571 股Common StockSEC:0001680739-26-000015:0
75 股Common StockSEC:0001680739-26-000015:1
4,500 股Common StockSEC:0001680739-26-000014:0
4,500 股Common StockSEC:0001680739-26-000014:1
4,000 股0Common StockSEC:0001680739-26-000012:0
83 股Common StockSEC:0001680739-26-000006:0
8,000 股@ US$17.940.0026% mcap4.7% 占其流量Common StockSEC:0001680739-26-000005:0
9,000 股@ US$15.430.0025% mcap4.5% 占其流量Common StockSEC:0001680739-26-000005:1
4,500 股@ US$18.270.0015% mcap2.7% 占其流量Common StockSEC:0001680739-26-000005:2
4,500 股@ US$21.380.0017% mcap3.2% 占其流量Common StockSEC:0001680739-26-000005:3
6,750 股@ US$17.110.0021% mcap3.8% 占其流量Common StockSEC:0001680739-26-000005:4
26,000 股@ US$41.070.019% mcap35.0% 占其流量Common StockSEC:0001680739-26-000005:5
6,750 股@ US$42.120.0051% mcap9.3% 占其流量Common StockSEC:0001680739-26-000005:6
10,000 股@ US$26.520.0058% mcap24.1% 占其流量Common StockSEC:0001680739-26-000003:0
10,000 股@ US$33.000.0072% mcap30.0% 占其流量Common StockSEC:0001680739-26-000003:1
70 股Common StockSEC:0001680739-26-000001:0
5,112 股@ US$40.9324.7% 占其流量Common StockSEC:0001680739-25-000007:0
93 股Common StockSEC:0001680739-25-000005:0
108 股Common StockSEC:0001415889-25-020514:0
2,143 股Common StockSEC:0001415889-25-018834:0
6,500 股0Common StockSEC:0001415889-25-013496:0
116 股Common StockSEC:0001415889-25-011550:0
10,000 股@ US$17.4417.6% 占其流量Common StockSEC:0001415889-25-003529:0
92 股Common StockSEC:0001415889-25-003068:0
16,000 股@ US$17.5028.2% 占其流量Common StockSEC:0001415889-25-002003:0
47 条申报中的 25 条
About Baynes Roy D.
Baynes Roy D. is an Administrateur at Natera, Inc., Travere Therapeutics, Inc. and Atara Biotherapeutics, Inc. The declarant has 47 filings in total, and across the sampled recent filings from 2021-05-18 to 2026-06-30, the aggregated amounts show €0 of buys and €1,431,862 of sells, with the modal transaction nature listed as Attribution.
